Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Philip Meuleman

Faculty of Medicine and Health Sciences > Department of Diagnostic Sciences

ORCID iD: 0000-0001-6821-234X

Show Sort by

Add to list
- Journal Article
- A1
- open access
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy

N Meumann, M Cabanes-Creus, M Ertelt, RG Navarro, J Lucifora, Q Yuan, K Nien-Huber, A Abdelrahman, XK Vu, L Zhang, et al.

(2023) HEPATOLOGY. 77(3). p.802-815
Add to list
- Journal Article
- A1
- open access
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Rani Burm (UGent) , Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Ahmed Atef Ahmed Abouzeid Mesalam (UGent) , S Ciesek, P Roingeard, H Wedemeyer, Geert Leroux-Roels (UGent) and Philip Meuleman (UGent)

(2023) JHEP REPORTS. 5(3).
Add to list
- Journal Article
- A1
- open access
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function

TL Meister, Y Brüggemann, MK Nocke, RG Ulrich, J Schuhenn, K Sutter, A Gömer, V Bader, KF Winklhofer, R Broering, et al.

(2022) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 119(34).
Add to list
- Journal Article
- A1
- open access
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice

M Kabbani, E Michailidis, S Steensels, CG Fulmer, JM Luna, J Le Pen, M Tardelli, B Razooky, I Ricardo-Lax, C Zou, et al.

(2022) CELL REPORTS. 40(11).
Add to list
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections

Rani Burm (UGent) , Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Anna Pasetto, Stephan Urban, Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Heiner Wedemeyer, et al.

(2022) GUT.
Add to list
- Journal Article
- A1
- open access
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

Christian Heuss, Paul Rothhaar, Rani Burm (UGent) , Ji-Young Lee, Philipp Ralfs, Uta Haselmann, Luisa J. Ströh, Ombretta Colasanti, Cong Si Tran, Noemi Schäfer, et al.

(2022) PLOS PATHOGENS. 18(6).
Add to list
- Journal Article
- A1
- open access
Viral interference of hepatitis C and E virus replication in novel experimental co-infection systems

T Burkard, N Proske, K Resner, Laura Collignon (UGent) , L Knegendorf, M Friesland, Lieven Verhoye (UGent) , IM Sayed, Y Brüggemann, MK Nocke, et al.

(2022) CELLS. 11(6).
Add to list
- Journal Article
- A1
- open access
Study of hepatitis E virus-4 infection in human liver-chimeric, immunodeficient, and immunocompetent mice

Laura Collignon (UGent) , Lieven Verhoye (UGent) , Renate Hakze-Van der Honing, Wim H. M. Van der Poel and Philip Meuleman (UGent)

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
A role for B cells to transmit hepatitis C virus infection

Isabelle Desombere (UGent) , Freya Van Houtte (UGent) , Aliasghar Farhoudi Moghadam (UGent) , Lieven Verhoye (UGent) , Caroline Buysschaert (UGent) , Yvonne Gijbels (UGent) , Sibyl Couvent (UGent) , W Swinnen, Hans Van Vlierberghe (UGent) , André Elewaut (UGent) , et al.

(2021) FRONTIERS IN IMMUNOLOGY. 12.
Add to list
- Journal Article
- A1
- open access
Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections

P Maravelia, L Frelin, Y Ni, NC Pérez, G Ahlén, N Jagya, G Verch, Lieven Verhoye (UGent) , L Pater, M Johansson, et al.

(2021) JOURNAL OF INFECTIOUS DISEASES. 223(1). p.128-138

1
2
3
4
…
14
15

Next →